Prescription bias, US law, & anti-epilepsy drugs

Drawing on literature in medicine, sociology, psychology, responsive regulation theory, and law, I highlight this important gap in American legislative frameworks and indeed in legal scholarship surrounding medicines.

I underscore key limitations in the current federal, state, and nongovernment regulatory regime surrounding prescribing requirements and medicines information-sharing, and I draw on anti-epilepsy drugs that give color and urgency to the issue of prescription bias given their pronounced risks for adverse drug reactions.<br><br>This Dissertation identifies how societal influences distort medical reasoning and lead to unsafe biased prescribing, and it considers limitations in the current regulatory regime surrounding prescribing, physicians’ medicines knowledge, and mitigating prescription bias.